Profil
Scott C.
Stromatt worked as a Director of Medical Affairs at G.D.
Searle & Co., Inc. and as a Vice President of Clinical Research at Synergen, Inc. He was also the EVP of Clinical Development & Regulatory Affairs at CTI BioPharma Corp.
and the Chief Medical Officer & VP of Clinical Research at Northwest Biotherapeutics, Inc. He served as the Senior Vice President at C.E.
Unterberg, Towbin Holdings, Inc. and as the Chief Medical Officer & Senior Vice President at Emergent Product Development Seattle and Emergent BioSolutions, Inc. He was also the Chief Medical Officer & SVP of Clinical Development at Aptevo Therapeutics, Inc. Dr. Stromatt earned a doctorate degree from The University of Chicago and an undergraduate degree and an MBA from The University of Colorado.
Anciens postes connus de Scott Stromatt
| Sociétés | Poste | Fin |
|---|---|---|
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical products | Directeur Technique/Scientifique/R&D | 01/08/2016 |
| CTI BIOPHARMA CORP. | Directeur Technique/Scientifique/R&D | 01/01/2008 |
| NORTHWEST BIOTHERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 02/10/2003 |
C. E. Unterberg, Towbin, Inc.
C. E. Unterberg, Towbin, Inc. Investment Banks/BrokersFinance Provides investment bank services in the technology, healthcare, and security/crime control/anti-terrorism industries | Analyst-Equity | 18/02/2002 |
| APTEVO THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Scott Stromatt
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Synergen, Inc.
Synergen, Inc. Electric UtilitiesUtilities Distributes electricity | Utilities |
CTI BioPharma Corp.
CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
Northwest Biotherapeutics, Inc.
Northwest Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes immunotherapy products | Health Technology |
C.E. Unterberg, Towbin Holdings, Inc.
C.E. Unterberg, Towbin Holdings, Inc. Investment ManagersFinance Provides financial advisory services | Finance |
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical products | Health Technology |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries Makes diversified line of chemicals and agricultural products | Process Industries |
C. E. Unterberg, Towbin, Inc.
C. E. Unterberg, Towbin, Inc. Investment Banks/BrokersFinance Provides investment bank services in the technology, healthcare, and security/crime control/anti-terrorism industries | Finance |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emergent BioSolutions, Inc.
Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Aptevo Therapeutics, Inc.
Aptevo Therapeutics, Inc. BiotechnologyHealth Technology Provides immunology and cancer research services | Health Technology |
















